HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Iván D Vélez Selected Research
Iván D Vélez Research Topics
Disease
10
Cutaneous Leishmaniasis
01/2020 - 08/2005
8
Leishmaniasis
01/2018 - 05/2006
4
Infections
01/2022 - 04/2012
2
Vivax Malaria
01/2022 - 01/2019
2
Pain (Aches)
01/2013 - 05/2012
1
Vomiting
01/2022
1
Body Weight (Weight, Body)
01/2022
1
Reinfection
01/2020
1
Visceral Leishmaniasis (Kala Azar)
06/2019
1
Weight Loss (Weight Reduction)
06/2019
1
Parasitemia
01/2019
1
Inflammation (Inflammations)
01/2018
1
Wounds and Injuries (Trauma)
01/2018
1
Neoplasms (Cancer)
05/2017
1
Myalgia
05/2012
1
Headache (Headaches)
05/2012
1
Fever (Fevers)
05/2012
1
Arthralgia (Joint Pain)
05/2012
1
Malaria
04/2010
1
Hypersensitivity (Allergy)
12/2009
1
Asymptomatic Infections
12/2009
Drug/Important Bio-Agent (IBA)
3
miltefosine (Impavido)
IBA
01/2013 - 01/2012
3
Meglumine Antimoniate
IBA
05/2012 - 05/2006
2
tafenoquine
IBA
01/2022 - 01/2019
2
Biological Products
IBA
11/2017 - 04/2010
2
Nitric Oxide (Nitrogen Monoxide)
FDA Link
07/2010 - 05/2006
2
Vaccines
IBA
12/2009 - 08/2005
1
Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)
IBA
01/2022
1
Tablets
IBA
01/2022
1
Peptide Hydrolases (Proteases)
FDA Link
01/2020
1
Hydrazones
IBA
01/2020
1
Saponins
IBA
01/2020
1
Hemoglobins (Hemoglobin)
IBA
06/2019
1
Gases
IBA
06/2019
1
Lactic Acid (Lactate)
FDA Link
Generic
06/2019
1
Primaquine
FDA Link
01/2019
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2018
1
Epidermal Growth Factor (EGF)
IBA
01/2018
1
Immunologic Factors (Immunomodulators)
IBA
01/2018
1
Biomarkers (Surrogate Marker)
IBA
01/2018
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2018
1
Chalcones
IBA
05/2017
1
hypericin
IBA
09/2015
1
quinoline
IBA
08/2015
1
Hydroxyl Radical
IBA
08/2015
1
Pharmaceutical Preparations
IBA
04/2012
1
S 27
IBA
01/2012
1
Liposomes (Liposome)
IBA
05/2010
1
Antigens
IBA
04/2010
Therapy/Procedure
3
Therapeutics
01/2019 - 01/2012
2
Secondary Prevention
01/2022 - 01/2019
2
Duration of Therapy
01/2013 - 05/2012
2
Induced Hyperthermia (Thermotherapy)
01/2013 - 05/2012
1
Photochemotherapy (Photodynamic Therapy)
09/2015
1
Aftercare (After-Treatment)
01/2013